| Name | Title | Contact Details |
|---|
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.
Wilson Ophthalmic Corp is a Mustang, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Elephant Pharmacy is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ChartSpan is a healthcare data company serving patients, providers and employers. Consumers use ChartSpan`s Patient Platform to manage their electronic healthcare records and information on their smartphone, tablet or computer. ChartSpan`s iPhone, iPad, Android and Android Tablet apps have all become the #1 most downloaded medical apps in the U.S. Providers (hospitals, clinics and doctors) leverage ChartSpan`s consumer products to deliver world-class patient EaaS (Engagement-as-a-Service™) to their patients. Employers utilize ChartSpan`s consumer products to manage wellness and healthcare analytics within its employee population.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.